Grm. While et al., Isolation and characterization of a human homologue of the latrophilin gene from a region of 1p31.1 implicated in breast cancer, ONCOGENE, 17(26), 1998, pp. 3513-3519
We have identified a region of chromosome 1p31.1 that shows high frequency
loss of heterozygosity (LOH) in human breast cancer. This region forms part
of a 7 Mb YAC/BAC contig, In order to identify candidate sequences, mutati
on of which might contribute to the development of disease, we have carried
out mapping studies of ESTs localized to 1p31.1. This analysis, coupled wi
th library screening and a modified 5' RACE-PCR strategy, resulted in the i
dentification and characterization of a novel gene (LPHH1) which is located
adjacent to the smallest region of overlapping loss (SRO) seen in tumours,
The 4209 bp open reading frame of the 7 kb LPHH1 transcript encodes a pept
ide which shows approximately 65% identity to rat latrophilin, a G-coupled,
seven span transmembrane protein, which binds alpha-latrotoxin. In the hum
an sequence, whilst conservation of the transmembrane domain is high, the i
ntra- and extracellular domains show two regions of variable structure, whi
ch are presumably generated by alternative splicing. Surprisingly, while ex
pression of the rat gene is tightly restricted to neurological and perhaps
some endocrine cells, the human sequence appears to be expressed very widel
y in all normal tissues tested. Northern and RT-PCR analysis of a panel of
tumour cell lines showed that LPHH1 expression was variable, apparently ele
vated in some lines and absent or markedly reduced in others. Furthermore,
characterization of the range of transcripts encoded in a breast tumour cel
l line, compared to normal breast, suggested that gene product variability
was higher in the tumour.